BSE 811.30 NSE 811.85
BSE 811.30 NSE 811.85

Christine Mundkur

Independent Director

Ms. Mundkur has almost three decades of experience in the pharmaceutical industry. Most recently, she served as CEO and Non-voting Chairman of the Board of Directors of Impopharma Inc., a developer of complex formulations focused on inhalation pharmaceutical products. In addition, she has held the position of President & CEO for North America for Sandoz Inc. Previously, she was the CEO of Barr Laboratories, Inc. Currently, she also serves on the Board of Directors of MannKind Corporation in the U.S.

  • Graduation as J.D. from the St. Louis University School of Law, St. Louis
  • B.S. degree in chemistry from the St. Louis University, St. Louis
Age 53 years
Nationality US
Appointed April 1, 2019
Tenure 3.0 years
Committee Membership Member of the Audit Committee, Nomination & Remuneration Committee and Risk Management Committee

Appointment Letter